Literature DB >> 7558923

Detailed motifs for peptide binding to HLA-A*0201 derived from large random sets of peptides using a cellular binding assay.

J W Drijfhout1, R M Brandt, J D'Amaro, W M Kast, C J Melief.   

Abstract

Extensive sets of in total about 2000 synthetic peptides were investigated for their binding affinities to HLA-A*0201. Comparisons of the amino acid compositions of binding to nonbinding sets of peptides provided new information concerning the rules for 9-, 10-, and 11-mer peptide binding at the amino acid level. Preferred primary anchors were shown to depend on peptide length, longer peptides being more demanding in this respect. A clear preference exists for certain amino acids at several nonanchor positions. In addition, the presence of particular amino acids at those positions almost completely precludes peptide binding. We found no evidence for preferred anchor pairs. From these results new and detailed HLA-A*0201 peptide-binding motifs for 9-, 10-, and 11-mer peptide binding were deduced. The motifs are in accordance with earlier reports but include new findings, including C as a C-terminal anchor, the importance of D at positions 4 for binding, and the deleterious effect of R at position 5 (in 9-mers). The motifs are presented in such a way that they can be used to predict peptide binding to HLA-A*0201 by computer analysis (see accompanying paper [56]).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558923     DOI: 10.1016/0198-8859(94)00151-f

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  10 in total

1.  The use of bovine MHC class I allele-specific peptide motifs and proteolytic cleavage specificities for the prediction of potential cytotoxic T lymphocyte epitopes of bovine viral diarrhea virus.

Authors:  N R Hegde; S Srikumaran
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.

Authors:  Gabrielle G M Pinkse; Odette H M Tysma; Cees A M Bergen; Michel G D Kester; Ferry Ossendorp; Peter A van Veelen; Bart Keymeulen; Danny Pipeleers; Jan W Drijfhout; Bart O Roep
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

3.  Prediction of potential cytotoxic T lymphocyte epitopes of bovine herpesvirus 1 based on allele-specific peptide motifs and proteolytic cleavage specificities.

Authors:  N R Hegde; S Srikumaran
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

4.  Enhanced In Vitro and In Vivo Potency of a T Cell Epitope in the Ebola Virus Glycoprotein Following Amino Acid Replacement at HLA-A*02:01 Binding Positions.

Authors:  Sylvie Chabot; Yusra Gimie; Karam Obeid; Jaekwan Kim; Clement A Meseda; Krishnamurthy Konduru; Gerardo Kaplan; Li Sheng Fowler; Jerry P Weir; Keith Peden; Marian E Major
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

5.  Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.

Authors:  S Peng; C Trimble; L He; Y-C Tsai; C-T Lin; D A K Boyd; D Pardoll; C-F Hung; T-C Wu
Journal:  Gene Ther       Date:  2006-01       Impact factor: 5.250

6.  ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery.

Authors:  Kathryn A K Finton; Mi-Youn Brusniak; Lisa A Jones; Chenwei Lin; Andrew J Fioré-Gartland; Chance Brock; Philip R Gafken; Roland K Strong
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

7.  pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL.

Authors:  G J Adema; A B Bakker; A J de Boer; P Hohenstein; C G Figdor
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

8.  Peptide Super-Agonist Enhances T-Cell Responses to Melanoma.

Authors:  Sarah A E Galloway; Garry Dolton; Meriem Attaf; Aaron Wall; Anna Fuller; Cristina Rius; Valentina Bianchi; Sarah Theaker; Angharad Lloyd; Marine E Caillaud; Inge Marie Svane; Marco Donia; David K Cole; Barbara Szomolay; Pierre Rizkallah; Andrew K Sewell
Journal:  Front Immunol       Date:  2019-03-13       Impact factor: 7.561

9.  Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.

Authors:  Daichao Wu; Alexander Kolesnikov; Rui Yin; Johnathan D Guest; Ragul Gowthaman; Anton Shmelev; Yana Serdyuk; Dmitry V Dianov; Grigory A Efimov; Brian G Pierce; Roy A Mariuzza
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

10.  Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen.

Authors:  Daichao Wu; D Travis Gallagher; Ragul Gowthaman; Brian G Pierce; Roy A Mariuzza
Journal:  Nat Commun       Date:  2020-06-09       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.